← Eichor
Study identifier: NCT05098769 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

Condition: Pulmonary Embolism and Thrombosis · Deterioration, Clinical  ·  Sponsor: Shengjing Hospital

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.

This description comes directly from the study's public registry record.

Talk to the study team

YIZHUO GAO  ·  +86-18940257523  ·  gaoyizhuo.sy@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shenjing Hospital of CHINA MEDICAL UNIVERSITYShenyang, Liaoning, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05098769